New Trends,2A self cleaving peptides do apparently work in bacteria

The use of 2A peptides has revolutionized gene expression by enabling the co-expression of multiple proteins from a single transcript. These viral-derived oligopeptides, typically 18-22 amino acids in length, function by co-translational ribosomal skipping, effectively "cleaving" the nascent polypeptide chain. However, researchers often encounter situations where the 2A peptide not working as expected, leading to fused proteins or incomplete expression. This article delves into the common reasons behind 2A peptide failure and provides actionable strategies to troubleshoot these issues, drawing upon extensive research and practical experience.

Understanding the Mechanism of 2A Peptides

Before addressing why your 2A peptide not working, it's crucial to understand its mechanism. 2A peptides, such as those derived from the foot-and-mouth disease virus (FMDV), do not undergo true proteolytic cleavage. Instead, they exploit a unique ribosomal mechanism. During translation, the 2A peptide sequence interacts with the ribosome's exit tunnel. This interaction causes the ribosome to skip the formation of a peptide bond between a glycine (Gly) residue within the 2A peptide and a proline (Pro) residue at its C-terminus. This results in the release of the upstream protein while translation continues, albeit with a residual proline tag on the downstream protein. This process is often referred to as "self-cleavage" or "ribosomal skipping."

Common Reasons for 2A Peptide Failure

Several factors can contribute to a 2A peptide not working correctly in your experimental setup. Identifying the specific cause is key to successful troubleshooting.

* Inefficient Ribosomal Skipping: The efficiency of ribosomal skipping can vary significantly between different 2A peptides and even between different gene contexts. Some studies have systematically compared various 2A peptides, such as T2A and P2A, finding differences in their efficiency. If the skipping is not efficient, you will observe unfused or tandem proteins, indicating the 2A peptide is not working. This can be a serious problem when equimolar expression is desired.

* Gene Context and Position Effects: The surrounding genetic sequence can influence 2A peptide function. The position of a gene within a polycistronic construct has been shown to affect protein expression levels. For instance, a systematic comparison of 2A peptides for cloning multi- genes in a polycistronic vector revealed that gene position matters. If your 2A peptide is not working, consider the possibility that the specific gene context is hindering its function. Some researchers suggest that swapping your tricky protein to position three in the vector could be a viable solution.

* Upstream and Downstream Protein Interactions: The nature of the proteins being expressed can also play a role. If the upstream protein is very large or has specific structural features, it might interfere with the ribosome's ability to perform the skipping event. Similarly, the downstream protein's sequence can influence the efficiency. For example, the N-terminal amino acids of the downstream protein, such as the proline remnant left by the 2A peptide, can sometimes affect protein stability. One study highlighted that the N-terminal proline remnant of the 2A peptide, alone or in combination with leucine, introduced during polycistronic cloning, can destabilize certain proteins like KLF4.

* Cell Line or Organism Specificity: While 2A peptides are widely used in eukaryotic systems, their functionality can differ across species or cell types. For example, the question of whether 2A self-cleaving peptides do apparently work in bacteria has been debated. While some evidence suggests they can function in bacteria, they are not commonly used in these chassis due to lower efficiency or potential for fused proteins. If you are working in a non-standard eukaryotic system, investigate if 2A peptides have been successfully implemented.

* Vector Design and Sequence Integrity: Errors in the plasmid design or sequence integrity can lead to 2A peptide failure. Ensure that the P2A DNA sequence or the sequence of your chosen 2A peptide is accurately synthesized and cloned into the vector. Mismatches or mutations within the 2A peptide sequence will prevent its proper function.

* N-terminal Signal Sequences: For secreted or membrane-anchored proteins expressed downstream of a 2A peptide, the presence of an N-terminal signal sequence is still required. A signal sequence is still required in genes downstream of a “self-cleaving” 2A peptide for secretary or membrane-anchored expression. Without it, the downstream protein will not be correctly targeted, even if the 2A peptide functions.

Troubleshooting Strategies When Your 2A Peptide Not Working

When you encounter issues with your 2A peptide, systematically work through these troubleshooting steps:

1. Verify the 2A Peptide Sequence: Double-check the exact sequence of the 2A peptide you are using. Different 2A sequences can work with different efficiencies, and some may leave more fused peptides than others. Ensure it is free from mutations.